By Rishika Sadam March 31 (Reuters) - Novo Nordisk has again cut the prices of its blockbuster diabetes and weight-loss drugs ...
The Danish drugmaker said it will cut the price of the starting dose of Ozempic by 36 percent and that of Wegovy by 48 ...
Novo Nordisk on Tuesday cut the prices of its diabetes and weight-loss drugs Ozempic and Wegovy by as much as 36% and 48% in ...
Ozempic's and Wegovy's lowest doses of 0.25 mg in India will now be priced at Rs. 1,415 for a weekly shot from Rs. 2,200 ...
Novo cuts Ozempic, Wegovy prices as generics hit India market. Semaglutide patent expiry sparks price war in India diabetes ...
Sun Pharma has launched Sematrinity, targeting diabetes, in two formulations priced between ₹3,000 and ₹5,200 per month, ...
Novo Nordisk has slashed Ozempic and Wegovy prices in India by up to 48% to stay competitive as generic alternatives enter ...
Novo Nordisk India has cut the prices of its diabetes and weight loss medicine brands Ozempic and Wegovy (GLP-1 receptor ...
Novo Nordisk reduces Ozempic and Wegovy prices by 36% and 48% in India, responding to new generics and patient feedback.
Novo Nordisk cuts prices of Wegovy and Ozempic in India by up to 48% amid rising competition from cheaper semaglutide ...
Novo Nordisk India revises pricing to make vital therapies more affordable for patients managing diabetes and obesity ...
Novo Nordisk has lowered Wegovy, Ozempic price in India in fight for market share with the likes of Dr Reddy's to Sun Pharma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results